Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1-negative Myeloproliferative Neoplasms Latium Group”

Maria Gabriella Mazzucconi, Ermina Baldacci, Roberto Latagliata, Massimo Breccia, Francesca Paoloni, Ambra Di Veroli, Michele Cedrone, Barbara Anaclerico, Nicoletta Villivà, Raffaele Porrini, Enrico Montefusco, Alessandro Andriani, Marco Montanaro, Laura Scaramucci, Antonio Spadea, Angela Rago, Giuseppe Cimino, Francesca Spirito, Cristina Santoro

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1-negative Myeloproliferative Neoplasms Latium Group”'. Together they form a unique fingerprint.

Medicine & Life Sciences